Jazz Pharmaceuticals gets FDA OK for cataplexy drug as it prepares to replace old cash cow
Following an FDA approval just last month for its small cell lung cancer drug, Jazz Pharmaceuticals keeps on rolling.
The Irish pharma announced Wednesday …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
